Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Neurosurgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.3171/2016.1.JNS151591PMID 27035164PMCID PMC5571827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles

  2015cited by this paper
• Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma

  2015cited by this paper
• Combination Therapy of Intraperitoneal Rapamycin and Convection- Enhanced Delivery of Nanoliposomal CPT-11 in Rodent Orthotopic Brain Tumor Xenografts.

  2015cited by this paper
• Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.

  2015cited by this paper
• Modelling convection-enhanced delivery in normal and oedematous brain

  2014cited by this paper
• Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

  2014cited by this paper
• Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy

  2014cited by this paper
• Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma

  2013cited by this paper
• Strong Cortical and Spinal Cord Transduction After AAV7 and AAV9 Delivery into the Cerebrospinal Fluid of Nonhuman Primates

  2013cited by this paper
• Garbage Truck of the Brain

  2013cited by this paper
• Convection-enhanced delivery catheter placements for high-grade gliomas: complications and pitfalls

  2012cited by this paper
• Neurosurgical Management and Prognosis of Patients With Glioblastoma That Progresses During Bevacizumab Treatment

  2012cited by this paper
• Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain.

  2012cited by this paper
• The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery.

  2012cited by this paper
• Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.

  2011cited by this paper
• Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan

  2011cited by this paper
• T2 Imaging in Monitoring of Intraparenchymal Real-Time Convection-Enhanced Delivery

  2011cited by this paper
• Image-guided convection-enhanced delivery of GDNF protein into monkey putamen.

  2011cited by this paper
• Image-guided convection-enhanced delivery platform in the treatment of neurological diseases

  2011cited by this paper
• Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.

  2011cited by this paper
• An evaluation of the relationships between catheter design and tissue mechanics in achieving high-flow convection-enhanced delivery.

  2011cited by this paper
• Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans

  2011cited by this paper
• Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitors.

  2011cited by this paper
• Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

  2010cited by this paper
• Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

  2010influential reference
• Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study

  2010cited by this paper
• Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.

  2010cited by this paper
• Optimized cannula design and placement for convection-enhanced delivery in rat striatum.

  2010cited by this paper
• Efficient gene therapy-based method for the delivery of therapeutics to primate cortex

  2009cited by this paper
• Nanocarriers’ entry into the cell: relevance to drug delivery

  2009cited by this paper
• ANATOMIC COMPRESSION CAUSED BY HIGH‐VOLUME CONVECTION‐ENHANCED DELIVERY TO THE BRAIN

  2009cited by this paper
• Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

  2008cited by this paper
• Phase 0 Clinical Trials: Conceptions and Misconceptions

  2008cited by this paper
• Assessment of a balloon-tipped catheter modified for intracerebral convection-enhanced delivery

  2008cited by this paper
• Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery.

  2008cited by this paper
• Diffusion in brain extracellular space.

  2008cited by this paper
• Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

  2007cited by this paper
• Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene — a phase I/II clinical protocol

  2007cited by this paper
• Blood-brain barrier delivery.

  2007cited by this paper
• Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter.

  2007cited by this paper
• Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.

  2007cited by this paper
• CONVECTION‐ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN‐13‐PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS: PHASE 1 STUDY OF FINAL SAFETY RESULTS

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note.

  2007cited by this paper
• Interstitial transport and transvascular fluid exchange during infusion into brain and tumor tissue.

  2007cited by this paper
• Convective delivery of glial cell line-derived neurotrophic factor in the human putamen.

  2007cited by this paper
• Convection-enhanced delivery of therapeutics for brain disease, and its optimization.

  2006cited by this paper
• Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.

  2006cited by this paper
• Real-time Imaging and Quantification of Brain Delivery of Liposomes

  2006cited by this paper
• Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study.

  2005cited by this paper
• Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues.

  2005cited by this paper
• Safety and Feasibility of Convection-enhanced Delivery of Cotara for the Treatment of Malignant Glioma: Initial Experience in 51 Patients

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents.

  2005cited by this paper
• Convection-Enhanced Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand with Systemic Administration of Temozolomide Prolongs Survival in an Intracranial Glioblastoma Xenograft Model

  2004cited by this paper
• Long Term Survival in a Patient with Recurrent Malignantc Glioma Treated with Intratumoral Infusion of an IL4-Targeted Toxin (NBI-3001)

  2004cited by this paper
• Targeted therapy for brain tumours

  2004cited by this paper
• Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

  2004cited by this paper
• Immunogene Therapy of Recurrent Glioblastoma Multiforme with a Liposomally Encapsulated Replication-Incompetent Semliki Forest Virus Vector Carrying the Human Interleukin-12 Gene – A Phase I/II Clinical Protocol

  2004cited by this paper
• Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.

  2003cited by this paper
• Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.

  2003cited by this paper
• Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

  2003cited by this paper
• Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas

  2003cited by this paper
• Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma

  2003cited by this paper
• Diffusion parameters of the extracellular space in human gliomas

  2003cited by this paper
• Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.

  2001influential reference
• Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.

  2000cited by this paper
• The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging.

  2000cited by this paper
• Tissue Distribution and Antitumor Activity of Topotecan Delivered by Intracerebral Clysis in a Rat Glioma Model

  2000cited by this paper
• Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials

  1999cited by this paper
• Comparison of 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion.

  1999cited by this paper
• Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics.

  1999cited by this paper
• Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time.

  1999cited by this paper
• A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

  1998cited by this paper
• A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase "Suicide" Gene Therapy for Recurrent Glioblastoma

  1998cited by this paper
• Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

  1997cited by this paper
• Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.

  1997cited by this paper
• Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

  1997cited by this paper
• A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy.

  1996cited by this paper
• Treatment of Advanced CNS Malignancies with the Recombinant Adenovirus H5.010RSVTK: A Phase I Trial. University of Pennsylvania Medical Center, Philadelphia

  1996cited by this paper
• Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.

  1996cited by this paper
• Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

  1996cited by this paper
• Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion.

  1995cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper
• Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.

  1994cited by this paper
• Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.

  1990cited by this paper
• Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.

  1990cited by this paper
• Comparative properties and methods of preparation of lipid vesicles (liposomes).

  1980cited by this paper

• Exploring the therapeutic potential of metal complexes in glioblastoma treatment: a focus on brain tumor targeting strategies

  2026cites this paper
• From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics

  2026cites this paper
• Targeting the glioblastoma resection margin with locoregional nanotechnologies

  2025cites this paper
• Imaging probes for the detection of brain microenvironment.

  2025cites this paper
• EGFRvIII-Targeted Virus-Like Particles Enable Selective Genome Editing and Elimination of Glioblastoma Cells

  2025cites this paper
• Decoding Brain Interstitial Transport In Vivo: A Fully Validated Bottom-Up Mechanistic Prediction Framework

  2025cites this paper
• IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma

  2025cites this paper
• Therapeutic manipulation and bypass of the blood-brain barrier: powerful tools in glioma treatment.

  2025cites this paper
• Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

  2025cites this paper
• Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma

  2025cites this paper
• A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma

  2025cites this paper
• Sonodynamic Therapy With Orally Absorbable Nanomedicine for Brain Tumor

  2025cites this paper
• Regenerative Glycopeptide Scaffolds Enhance BMP-4 Activity To Treat Pediatric Glioma

  2025cites this paper
• Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems

  2025cites this paper
• Polymeric nanoparticle-mediated GBA1 gene therapy is neuroprotective in a preclinical model of Parkinson’s disease

  2025cites this paper
• Drug delivery strategies for paediatric diffuse midline gliomas.

  2025cites this paper
• A Preliminary Study on the Accuracy of MRI-Guided Thalamic Infusion of AAV2-GFP and Biodistribution Analysis Using Cryo-Fluorescence Tomography in Nonhuman Primates

  2025cites this paper
• Navigating the Central Nervous System (CNS): A Pharmacokinetic Approach to the Treatment of CNS Tumors, Glioblastoma Multiforme (GBM), in Particular

  2025cites this paper
• Digital Twin Technology In Radiology.

  2025cites this paper
• Lipidomics-driven drug discovery and delivery strategies in glioblastoma.

  2024cites this paper
• Fluid flow and amyloid transport and aggregation in the brain interstitial space

  2024cites this paper
• Deciphering Convection Enhanced Delivery: A Paradigm Shift for Circumventing Glioblastoma Multiforme

  2024cites this paper
• Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study

  2024cites this paper
• Reducing Flow Resistance via Introduction and Enlargement of Microcracks in Convection Enhanced Delivery (CED) in Porous Tumors

  2024cites this paper
• Interleukin 6 and cancer resistance in glioblastoma multiforme

  2024cites this paper
• Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy

  2024cites this paper
• Targeted Radionuclide Therapy in Glioblastoma.

  2024cites this paper
• A Comprehensive Review on Modeling Aspects of Infusion-Based Drug Delivery in the Brain.

  2024cites this paper
• Image-guided patient-specific optimization of catheter placement for convection-enhanced nanoparticle delivery in recurrent glioblastoma

  2024cites this paper
• Potential of Photoelectric Stimulation with Ultrasmall Carbon Electrode on Neural Tissue: New Directions in Neurostimulation Technology Development

  2024cites this paper
• Fully flexible implantable neural probes for electrophysiology recording and controlled neurochemical modulation

  2024cites this paper
• Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies

  2024cites this paper
• Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors

  2024cites this paper
• Novel Clinical Trials and Approaches in the Management of Glioblastoma

  2024cites this paper
• Continuous iontronic chemotherapy reduces brain tumor growth in embryonic avian in vivo models.

  2024cites this paper
• Glioblastoma Margin as a Diffusion Barrier Revealed by Photoactivation of Plasmonic Nanovesicles.

  2024cites this paper
• Adjuvant convection-enhanced delivery for the treatment of brain tumors

  2024cites this paper
• Targeted Glioma Therapy—Clinical Trials and Future Directions

  2024cites this paper
• In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastoma

  2024cites this paper
• Convection-enhanced delivery of [177Lu]Lu-labeled gold nanoparticles combined with anti-PD1 checkpoint immunotherapy improves the survival of immunocompetent C57BL/6J mice with orthotopic GL261 murine glioma tumors.

  2024cites this paper
• Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges

  2024cites this paper
• Unlocking Dendrimers Future Potential for Brain-Specific Drug Delivery in Cerebroanoreach.

  2024cites this paper
• Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial

  2023cites this paper
• Personalised therapeutic approaches to glioblastoma: A systematic review

  2023cites this paper
• Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme

  2023cites this paper
• Evaluating drug distribution in children and young adults with diffuse midline glioma of the pons (DIPG) treated with convection-enhanced drug delivery

  2023cites this paper
• Controlled electroactive release from solid-state conductive elastomer electrodes

  2023cites this paper
• Drug Delivery to the Brain: Recent Advances and Unmet Challenges

  2023cites this paper
• Layer-by-Layer Polymer Functionalization Improves Nanoparticle Penetration and Glioblastoma Targeting in the Brain.

  2023cites this paper
• Surgical Management and Advances in the Treatment of Glioma

  2023cites this paper
• Glioblastoma Margin as a Diffusion Barrier Revealed by Photoactivation of Plasmonic Nanovesicles

  2023cites this paper
• Dual‐Responsive Nanorobot‐Based Marsupial Robotic System for Intracranial Cross‐Scale Targeting Drug Delivery

  2023cites this paper
• MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma

  2023cites this paper
• A Highly Translatable Dual-arm Local Delivery Strategy To Achieve Widespread Therapeutic Coverage in Healthy and Tumor-bearing Brain Tissues.

  2023cites this paper
• Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial

  2023cites this paper
• Bioreducible Gene Delivery Platform that Promotes Intracellular Payload Release and Widespread Brain Dispersion.

  2023cites this paper
• The Surgical Management of Diffuse Gliomas: Current State of Neurosurgical Management and Future Directions.

  2023cites this paper
• μMESH-Enabled Sustained Delivery of Molecular and Nanoformulated Drugs for Glioblastoma Treatment

  2023cites this paper
• Infusion of Therapeutic Agents to the Brain (Convection-Enhanced Intraparenchymal Delivery)

  2022cites this paper
• Advances in local therapy for glioblastoma — taking the fight to the tumour

  2022cites this paper
• Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints

  2022cites this paper
• Applications of nanodiamonds in the diagnosis and treatment of neurological diseases

  2022cites this paper
• Current approaches of nanomedicines in the market and various stage of clinical translation

  2022cites this paper
• Mechanism of extracellular space changes in cryptococcal brain granuloma revealed by MRI tracer

  2022influential citation
• Nanomedicine approaches for medulloblastoma therapy

  2022cites this paper
• Graphene Oxide Nanoscale Platform Enhances the Anti‐Cancer Properties of Bortezomib in Glioblastoma Models

  2022cites this paper
• Application of Biomaterials for Glioblastoma Treatment: Promises, Advances, and Challenges

  2022cites this paper
• Chronic convection-enhanced intratumoural delivery of chemotherapy for glioblastoma.

  2022cites this paper
• High Incidence of Intracerebral Hemorrhaging Associated with the Application of Low-Intensity Focused Ultrasound Following Acute Cerebrovascular Injury by Intracortical Injection

  2022cites this paper
• Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications.

  2022cites this paper
• A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art

  2022cites this paper
• Magnetic resonance imaging analysis predicts nanoparticle concentration delivered to the brain parenchyma

  2022cites this paper
• Characterization of passive permeability after low intensity focused ultrasound mediated blood–brain barrier disruption in a preclinical model

  2022cites this paper
• Convection-Enhanced Delivery in Children: Techniques and Applications.

  2022cites this paper
• Application of Biocompatible Drug Delivery Nanosystems for the Treatment of Naturally Occurring Cancer in Dogs

  2022cites this paper
• Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors.

  2022cites this paper
• The influence of the blood–brain barrier in the treatment of brain tumours

  2022cites this paper
• Influence of Acoustic Parameters and Sonication Schemes on Transcranial Blood–Brain Barrier Disruption Induced by Pulsed Weakly Focused Ultrasound

  2022cites this paper
• Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.

  2022cites this paper
• Leveraging the Neurosurgical Operating Room for Therapeutic Development in NeuroOncology.

  2022cites this paper
• Targeted Delivery of DNA Topoisomerase Inhibitor SN38 to Intracranial Tumors of Glioblastoma Using Sub‐5 Ultrafine Iron Oxide Nanoparticles

  2022cites this paper
• Insights into Infusion-Based Targeted Drug Delivery in the Brain: Perspectives, Challenges and Opportunities

  2022cites this paper
• Liposomal IR-780 as a Highly Stable Nanotheranostic Agent for Improved Photothermal/Photodynamic Therapy of Brain Tumors by Convection-Enhanced Delivery

  2021cites this paper
• Novel Treatment Approaches for Brain Tumour from a Blood-Brain Barrier Perspective.

  2021cites this paper
• Recent insight into the role of RING-finger E3 ligases in glioma.

  2021cites this paper
• Convection-enhanced drug delivery for glioblastoma: a review

  2021cites this paper
• Natural polymeric nanocarriers in malignant glioma drug delivery and targeting

  2021cites this paper
• Therapeutic Delivery to Central Nervous System.

  2021cites this paper
• Conformable hierarchically engineered polymeric micromeshes enabling combinatorial therapies in brain tumours

  2021cites this paper
• Diagnosis and Management of Glioblastoma: A Comprehensive Perspective

  2021cites this paper
• Convection Enhanced Delivery in the Setting of High-Grade Gliomas

  2021influential citation
• Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance

  2021cites this paper
• Patient specific, imaging-informed modeling of rhenium-186 nanoliposome delivery via convection-enhanced delivery in glioblastoma multiforme

  2021cites this paper
• A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma

  2021cites this paper
• Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma

  2021cites this paper
• Can we rely on synthetic pharmacotherapy for the treatment of glioblastoma?

  2021cites this paper
• An Update on Gene Therapy Approaches for Parkinson’s Disease: Restoration of Dopaminergic Function

  2021cites this paper
• Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

  2021cites this paper
• On the microstructural origin of brain white matter hydraulic permeability

  2021cites this paper
• The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors.

  2021cites this paper